Precision Health: Personalizing Treatment for Better Outcomes

Healthcare has traditionally operated on a one-size-fits-all approach-a model where treatments and medications are developed for the “average patient.” But what if your doctor could tailor your medical care specifically to your genetic makeup, lifestyle, and environment? This is the promise of precision health, and it’s fundamentally reshaping how we prevent, diagnose, and treat diseases. From smartphone apps that track cardiovascular risk to breakthrough cancer drugs targeting specific genetic mutations, precision health represents one of the most significant shifts in modern medicine.

What is precision health?
The core components
Real-world applications and initiatives
Stanford Medicine’s MyHeart Counts app
The U.S. Precision Medicine Initiative
Imatinib (Gleevec): precision medicine in action
Advantages of precision health
Earlier and more accurate diagnosis
Targeted and cost-effective treatments
Identification of at-risk populations
Improved quality of life
The road ahead

What is precision health?

Precision health is an innovative approach that tailors disease prevention and treatment by accounting for differences in people’s genes, environments, and lifestyles. Unlike conventional medicine that develops treatments based on how the average person responds, precision health recognizes that each individual is unique-and their healthcare should reflect that.

The National Research Council prefers the term “precision medicine” over “personalized medicine” because precision medicine focuses on identifying which approaches work best for specific patient groups based on genetic, environmental, and lifestyle factors, rather than implying that each person receives a uniquely designed treatment.

Precision health goes even broader than precision medicine. According to the Centers for Disease Control and Prevention (CDC), precision health encompasses precision medicine but also includes approaches beyond the clinical setting, such as disease prevention and health promotion activities that individuals can pursue on their own.

The core components

Precision health integrates multiple data streams to create a comprehensive picture of individual health. This includes genomic information that reveals inherited disease risks and drug responses, environmental factors such as pollution exposure, diet, and physical activity, and lifestyle data covering sleep patterns, stress levels, and daily habits. By combining these elements, healthcare providers can move beyond reactive treatment to proactive, preventive care that anticipates health problems before they develop.

The approach relies heavily on biomarker testing and genetic analysis to guide decisions. For instance, pharmacogenomics-the study of how genes affect drug response-allows doctors to prescribe medications and dosages most likely to be safe and effective for each patient, reducing the trial-and-error approach that has long characterized pharmaceutical treatment.

Real-world applications and initiatives

Precision health has moved well beyond theoretical frameworks into practical applications that are already improving patient outcomes. Several notable initiatives demonstrate how this approach works in practice.

Stanford Medicine’s MyHeart Counts app

One pioneering example of precision health in action is the MyHeart Counts app developed by Stanford Medicine in collaboration with Apple. Launched in 2015, this iPhone application collects data about physical activity and cardiac risk factors to help researchers study cardiovascular health at an unprecedented scale.

The app uses Apple’s ResearchKit framework to gather participant data, and researchers designed it to be the largest study of measured physical activity and cardiovascular health ever conducted. Participants can track their activity through their iPhone’s sensors or connected wearable devices, complete a six-minute walking fitness assessment, and input blood pressure and cholesterol readings to calculate their risk score for heart disease or stroke.

According to Stanford cardiologist Michael McConnell, the study has two major goals: collecting broad data on physical activity, fitness, and cardiovascular risk factors, and studying ways to help people enhance activity and decrease their chances of heart disease. The app provides personalized information about heart health while contributing to fundamental research insights about how activity affects cardiac outcomes across different ages, genders, and populations worldwide.

The U.S. Precision Medicine Initiative

On a national scale, the Precision Medicine Initiative (PMI) represents America’s most ambitious effort to advance precision health. Announced by President Obama in his 2015 State of the Union address, this long-term research endeavor involves the National Institutes of Health (NIH) and multiple research centers working to understand how genetics, environment, and lifestyle can determine the best approaches to prevent or treat disease.

The initiative has both near-term and long-term objectives. Its short-term focus centers on expanding precision medicine in cancer research, with researchers at the National Cancer Institute working to leverage increased knowledge of cancer genetics and biology to develop more effective treatments. The long-term goal involves bringing precision medicine to all areas of health and healthcare on a massive scale.

Central to this effort is the All of Us Research Program, which aims to gather health data from one million or more U.S. volunteers. Unlike traditional studies focused on specific diseases or populations, All of Us serves as a national research resource to inform thousands of studies across diverse health conditions. Participants contribute their genetic information, medical records, and lifestyle data to help researchers understand how individual differences influence health and disease.

Imatinib (Gleevec): precision medicine in action

Perhaps no drug better exemplifies the success of precision medicine than imatinib, marketed as Gleevec. This breakthrough medication transformed the treatment of chronic myelogenous leukemia (CML) from a death sentence into a manageable condition.

The story begins in 1960, when researchers Peter Nowell and David Hungerford discovered an abnormally short chromosome-later named the Philadelphia chromosome-in the cancer cells of CML patients. Subsequent research revealed that this chromosome forms when two genes that are normally separated become fused together, creating a hybrid called BCR-ABL. This fusion protein drives the uncontrolled growth of leukemia cells.

In the 1990s, researcher Brian Druker hypothesized that a drug blocking BCR-ABL could kill CML cells while leaving healthy cells intact, since normal cells don’t have this mutation. Working with pharmaceutical scientists, he identified a compound remarkably effective at killing CML cells. Clinical trials showed the drug caused cancer to disappear in the majority of patients with early-phase CML, and long-term data demonstrated that 83% of patients survived 10 years or longer on the medication.

The drug received FDA approval in 2001 and was hailed as a “magical bullet” that revolutionized cancer treatment. As noted by the National Cancer Institute, the introduction of imatinib resulted in near-normal life expectancy for CML patients who previously had very poor prognoses. Today, someone with CML who achieves remission after two years of imatinib treatment has essentially the same life expectancy as someone without cancer.

Beyond its direct impact on CML patients, imatinib established the entire category of targeted therapies-drugs designed to attack cancer cells with specific genetic abnormalities rather than killing all rapidly dividing cells like traditional chemotherapy. This precision approach has since expanded to numerous other cancers and conditions.

Advantages of precision health

The shift toward precision health offers substantial benefits for patients, healthcare systems, and society at large.

Earlier and more accurate diagnosis

Precision health enables the detection of diseases at much earlier stages, often before symptoms appear. By analyzing genetic markers and other biomarkers, physicians can identify individuals at elevated risk for conditions like cancer, heart disease, or diabetes and intervene before the disease progresses. The Jackson Laboratory notes that this approach is helping shift medicine from being reactive-waiting until diseases occur to treat them-to being truly preventive.

Targeted and cost-effective treatments

Traditional drug development produces treatments that work well for some patients but not others due to genetic differences. On average, any given prescription drug works for only about half of those who take it, according to research from the Jackson Laboratory. Precision health addresses this inefficiency by matching patients to treatments most likely to benefit them specifically.

While precision medicine approaches can initially appear expensive, they often prove more cost-effective over time by avoiding ineffective treatments, reducing adverse drug reactions, and preventing disease progression that would require more intensive intervention. The Cleveland Clinic explains that providers can develop prevention and treatment plans tailored to individuals rather than using the same approach for everyone.

Identification of at-risk populations

Precision health extends beyond individual treatment to population-level insights. By analyzing genetic and environmental data across large groups, researchers can identify populations at elevated risk for specific conditions. This enables targeted public health interventions and screening programs that focus resources where they’re most needed.

The approach also helps families. When genetic testing reveals that someone carries mutations associated with hereditary cancers, for example, family members can be tested and offered enhanced screening or preventive measures if they share the same genetic risk factors.

Improved quality of life

Perhaps most importantly, precision health helps individuals lead healthier, longer lives by providing care specifically tailored to their unique characteristics. Rather than enduring treatments that may be ineffective or cause unnecessary side effects, patients receive therapies optimized for their biology. The CDC emphasizes that precision health includes steps everyone can take to protect their own health, supported by mobile devices that monitor behaviors and remind people to take medications, exercise, and attend regular checkups.

The road ahead

Precision health is still evolving. Not every disease has precision treatments available yet, and access to these approaches varies depending on where people live and what their insurance covers. The costs of genetic testing and specialized medications remain concerns, and translating vast amounts of genomic data into actionable clinical guidance presents ongoing challenges.

Nevertheless, the trajectory is clear. As technologies improve and costs decrease, precision health will increasingly become the standard of care rather than the exception. The one-size-fits-all era of medicine is giving way to an approach that recognizes and responds to human diversity-one patient at a time.

What do you think? How might precision health change your own approach to healthcare decisions? And as these technologies become more widespread, how should societies balance the benefits of personalized medicine against concerns about genetic privacy and equitable access?

References

PDF 📄

Precision Health: Personalizing Treatment for Better Outcomes

Table of Contents

What is precision health? 🔗

The core components 🔗

Real-world applications and initiatives 🔗

Stanford Medicine’s MyHeart Counts app 🔗

The U.S. Precision Medicine Initiative 🔗

Imatinib (Gleevec): precision medicine in action 🔗

Advantages of precision health 🔗

Earlier and more accurate diagnosis 🔗

Targeted and cost-effective treatments 🔗

Identification of at-risk populations 🔗

Improved quality of life 🔗

The road ahead 🔗